A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine
Reuters | Oct 15, 2021 11:32 PM EDT
A vial of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine is seen during a vaccination event hosted by Miami - Dade County and Miami Heat, at FTX Arena in Miami, Florida, U.S.,
Most Popular
-
Challenges and Strategies in Building and Leading Diverse Teams
-
Demystifying Casino App Revenue: Understanding In-App Purchases and Microtransactions
-
U.S. Set to Impose Major Sanctions on Russia Following Navalny's Death
-
Tips for Students Struggling to Find Inspiration for Essay Writing
-
Reasons Why You Are So Slow At Writing Essays Awesome
-
Narrative Essay Topics: How To Choose Them?